15 participants
JAK 1/2 Inhibitor, Baricitinib, in the Treatment of Adult IIM
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2023-10-18
- Start Date:
- 2021-10-07
- Completion:
- 2023-09-25
Conditions
- Idiopathic Inflammatory Myopathies
Interventions
- DRUG
No Results Yet